Mismatch repair genes expression defects & association with clinicopathological characteristics in colorectal carcinoma

Indian Journal of Medical Research

Volumn 134, Issue 8, 2011, Pages 186-192

  Kaur, Gurjeet ^a,b   Masoud, Abdelhafid ^b   Raihan, N ^c   Radzid, M ^c   Khamizar, W ^c   Kam, Lee Suk ^d  

^a INSTITUTE FOR RESEARCH IN MOLECULAR MEDICINE INFORMM   (Malaysia)

^b ADVANCED MEDICAL AND DENTAL INSTITUTE   (Malaysia)

^c Hospital Sultanah Bahiyah   (Malaysia)

^d HOSPITAL PULAU PINANG   (Malaysia)

Author keywords

Colorectal carcinoma; Malaysia; Mismatch repair gene protein

Indexed keywords

MICROSATELLITE INSTABILITY HIGH 1; MICROSATELLITE INSTABILITY HIGH 2; MICROSATELLITE INSTABILITY HIGH 6; MISMATCH REPAIR PROTEIN; MISMATCH REPAIR PROTEIN PMS2; NUCLEIC ACID BINDING PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; COLORECTAL CARCINOMA; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALAYSIA; MALE; MICROSATELLITE INSTABILITY; PROTEIN EXPRESSION;

EID: 80054726376     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Lim GCC, Rampal S, Halimah Y, editors. In: Second report of the National Cancer Registry, Cancer Incidence in Malaysia 2003. Kuala Lumpur: National Cancer Registry; 2008.
2. Boland CR, Koi M, Chang DK, Carethers JM. The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedside. Fam Cancer 2008; 7: 41-52.
3. Lindor NM, Burgart LJ, Leontovich O, Goldberg RM, Cunningham JM, Sargent DJ, et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 2002; 20: 1043-8.
4. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998; 58: 5248-57.
5. Wheeler JM, Bodmer WF, Mortensen NJ. DNA mismatch repair genes and colorectal cancer. Gut 2000; 47: 148-53.
6. Grady WM. Genomic instability and colon cancer. Cancer Metastasis Rev 2004; 23: 11-27.
7. Yang B. Epigenetics: DNA hypermethylation in cancer. In: Tubbs RR, Stoler MH, editors. Cell and tissue based molecular pathology. Philadelphia, PA: Churchill Livingstone, Elsevier; 2009. p. 84-90.
8. Jass JR. HNPCC and sporadic MSI-H colorectal cancer: a review of the morphological similarities and differences. Fam Cancer 2004; 3: 93-100.
9. Kim H, Jen J, Vogelstein B, Hamilton SR. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol 1994; 145: 148-56.
10. Jass JR, Do KA, Simms LA, Lino H, Wynter C, Pillay SP, et al. Morphology of sporadic colorectal cancer with DNA replication errors. Gut 1998; 42: 673-9.
11. Jass JR, Walsh MD, Barker M, Simms LA, Young J, Leggett BA. Distinction between familial and sporadic forms of colorectal cancer showing DNA microsatellite instability. Eur J Cancer 2002; 38: 858-66.
12. Ruszkiewicz A, Bennett G, Moore J, Manavis J, Rudzki B, Shen L, et al. Correlation of mismatch repair genes immunohistochemistry and microsatellite instability status in HNPCC-associated tumours. Pathology 2002; 34: 541-7.
13. Shia J. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry. J Mol Diagn 2008; 10: 293-300.
14. Shia J, Ellis NA, Klimstra DS. The utility of immunohistochemical detection of DNA mismatch repair gene proteins. Virchows Arch 2004; 445: 431-41.
15. Shia J, Klimstra DS, Nafa K, Offit K, Guillem JG, Markowitz AJ, et al. Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms. Am J Surg Pathol 2005; 29: 96-104.
16. Southey MC, Jenkins MA, Mead L, Whitty J, Trivett M, Tesoriero AA, et al. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. J Clin Oncol 2005; 23: 6524-32.
17. Stone JG, Robertson D, Houlston RS. Immunohistochemistry for MSH2 and MHL1: a method for identifying mismatch repair deficient colorectal cancer. J Clin Pathol 2001; 54: 484-7.
18. Marcus VA, Madlensky L, Gryfe R, Kim H, So K, Millar A, et al. Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol 1999; 23: 1248-55.
19. Paraf F, Gilquin M, Longy M, Gilbert B, Gorry P, Petit B, et al. MLH1 and MSH2 protein immunohistochemistry is useful for detection of hereditary non-polyposis colorectal cancer in young patients. Histopathology 2001; 39: 250-8.
20. Christensen M, Katballe N, Wikman F, Primdahl H, Sorensen FB, Laurberg S, et al. Antibody-based screening for hereditary nonpolyposis colorectal carcinoma compared with microsatellite analysis and sequencing. Cancer 2002; 95: 2422-30.
21. Naing L, Winn T, Rusli BN. Sample size calculator for estimations, Version 1.0.03. Available at: http://www.kck.usm.my/ppsg/stats_resources.htm, accessed on December 20, 2009.
22. Pai RK, Wilcox R, Hart J. Molecular gastrointestinal, liver, and pancreatic pathology. In: Tubbs RR, Stole MH, editors. Cell and tissue based molecular pathology. Philadelphia, PA: Churchill Livingstone; 2009. p. 269-93.
23. Muller W, Burgart LJ, Krause-Paulus R, Thibodeau SN, Almeida M, Edmonston TB, et al. The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) - results of an international collaborative study. Fam Cancer 2001; 1: 87-92.